Anti-Human HER2 Therapeutic Antibody (Anti-HER2-IgGl)
The Her2 Antibody-Drug Conjugates comprise a drug moiety, an anti-HER2 antibody and a hydrophilic self-immolative linker. The antibody in this ADC compound specifically target human epidermal growth factor receptor 2 protein (HER2), which is a member of the epidermal growth factor family that are known to play an important role in both development and oncogenesis. Therefore the HER2 ADC can be used in the treatment of breast cancer, gastric cancer and ovarian cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-0195CL |
| Pricing | Inquiry |
| Type | Human antibody |
| Host | Human |
| Target | Her2 |